Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suzanne Cory

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Disease Models & Mechanisms|June 6, 2022
Joan Heath interviews Suzanne Cory and Joan Steitz: a female perspective of science in the swinging '60sJoan Heath, Suzanne Cory, Joan Steitz
Journal of Cell Science|April 12, 2012
BH3-only proteins in apoptosis at a glanceLina Happo, Andreas Strasser, Suzanne Cory
The EMBO Journal|August 25, 2011
Deciphering the rules of programmed cell death to improve therapy of cancer and other diseasesAndreas Strasser, Suzanne Cory, Jerry M Adams
Proceedings of the National Academy of Sciences of the United States of America|April 14, 2004
Bim is a suppressor of Myc-induced mouse B cell leukemiaAlexander Egle, Alan W Harris, Philippe Bouillet, et al.
Blood|July 3, 2014
Plasmacytomagenesis in Eμ-v-abl transgenic mice is accelerated when apoptosis is restrainedCassandra J Vandenberg, Paul Waring, Andreas Strasser, et al.
Oncogene|November 25, 2003
The Bcl-2 family: roles in cell survival and oncogenesisSuzanne Cory, David C S Huang, Jerry M Adams
Oncogene|February 3, 2005
T-cell lymphomas mask slower developing B-lymphoid and myeloid tumours in transgenic mice with broad haemopoietic expression of MYCDarrin P Smith, Mary L Bath, Alan W Harris, et al.
Trends in Cancer|July 26, 2017
Targeting BCL-2-like Proteins to Kill Cancer CellsSuzanne Cory, Andrew W Roberts, Peter M Colman, et al.
Blood|November 25, 2003
VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasiaAlexander Egle, Alan W Harris, Mary L Bath, et al.
Blood|March 16, 2006
MYC levels govern hematopoietic tumor type and latency in transgenic miceDarrin P Smith, Mary L Bath, Donald Metcalf, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Disease Models & Mechanisms|June 6, 2022
Joan Heath interviews Suzanne Cory and Joan Steitz: a female perspective of science in the swinging '60sJoan Heath, Suzanne Cory, Joan Steitz
Journal of Cell Science|April 12, 2012
BH3-only proteins in apoptosis at a glanceLina Happo, Andreas Strasser, Suzanne Cory
The EMBO Journal|August 25, 2011
Deciphering the rules of programmed cell death to improve therapy of cancer and other diseasesAndreas Strasser, Suzanne Cory, Jerry M Adams
Proceedings of the National Academy of Sciences of the United States of America|April 14, 2004
Bim is a suppressor of Myc-induced mouse B cell leukemiaAlexander Egle, Alan W Harris, Philippe Bouillet, et al.
Blood|July 3, 2014
Plasmacytomagenesis in Eμ-v-abl transgenic mice is accelerated when apoptosis is restrainedCassandra J Vandenberg, Paul Waring, Andreas Strasser, et al.
Oncogene|November 25, 2003
The Bcl-2 family: roles in cell survival and oncogenesisSuzanne Cory, David C S Huang, Jerry M Adams
Oncogene|February 3, 2005
T-cell lymphomas mask slower developing B-lymphoid and myeloid tumours in transgenic mice with broad haemopoietic expression of MYCDarrin P Smith, Mary L Bath, Alan W Harris, et al.
Trends in Cancer|July 26, 2017
Targeting BCL-2-like Proteins to Kill Cancer CellsSuzanne Cory, Andrew W Roberts, Peter M Colman, et al.
Blood|November 25, 2003
VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasiaAlexander Egle, Alan W Harris, Mary L Bath, et al.
Blood|March 16, 2006
MYC levels govern hematopoietic tumor type and latency in transgenic miceDarrin P Smith, Mary L Bath, Donald Metcalf, et al.
Pageof 4